Ranked above it

Care Bare Rx
Tells you exactly what you're buying — but $199 is a starting point, not a rate.
#1 on our semaglutide provider ranking, above MadeMed at #112.
Read the Care Bare Rx review →
Provider review
Advertises “From $199/mo” and sells no monthly plan at all.
Its own product data returns zero for every monthly, yearly and one-time option. Only quarterly and six-month prepay can be bought, so the cheapest way in is $717 charged up front.
Reviewed by Marcus Webb
Transparency scorecard
2 of 4 disclosed openly
What MadeMed discloses about itself, read from its own pages — not estimated.
Pharmacy named & regulated
Not disclosed
Does not name a pharmacy or state a regulatory category anywhere on its own site.
State coverage published
Disclosed
Publishes which states it actually serves.
A real price is published
Disclosed
A real dollar figure is published on its own site, not estimated.
No hidden commitment trap
Not disclosed
The advertised price requires a prepay, auto-refill, or other commitment we found and named.
This review's stake, stated plainly — some of the outbound links on this site are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.
Ranked above it

Care Bare Rx
Tells you exactly what you're buying — but $199 is a starting point, not a rate.
#1 on our semaglutide provider ranking, above MadeMed at #112.
Read the Care Bare Rx review →What this price covers
Medication
Included
Provider visits
Not confirmed
Shipping
Not confirmed
Lab work
Not confirmed
Coaching
Not confirmed
The catch — The advertised per-month price describes a plan that cannot be bought. Its own product API returns zero for monthly, yearly and one-time on every GLP-1 item, and the on-page toggle offers only Quarterly and 6-month while rendering both as “$X/month” and captioning the button with a per-month figure. Combined with a stated policy of no prorated refunds, the real minimum exposure is a three- to four-figure non-refundable charge.
See plans at MadeMedPrices read from MadeMed's own site · August 2026
What they advertise
“From $199/mo” for injectable semaglutide, “From $369/mo” for injectable tirzepatide, and “From $179” and “From $279” for the oral versions.
What you actually pay
There is no monthly rate, because there is no monthly plan. Injectable semaglutide is $717 for three months ($239/mo) or $1,194 for six ($199/mo). Injectable tirzepatide is $1,197 for three ($399/mo) or $2,214 for six ($369/mo). Oral semaglutide is $657 or $1,074; oral tirzepatide $897 or $1,674. Every advertised figure is the six-month prepay divided by six.
Money you will meet later
MadeMed (mademed.com) sells compounded semaglutide and tirzepatide as injections and as sublingual tablets, advertising each as “From $X/mo.” No monthly plan exists. Its own product data returns zero for the monthly, yearly and one-time options on all 21 GLP-1 items, leaving quarterly and six-month prepay as the only purchasable terms — so starting injectable semaglutide means paying $717 today, and tirzepatide $1,197. The advertised per-month figure is the six-month prepay divided by six. Set against that is something genuinely good and genuinely rare: its flat pricing across doses is real, verified against the pricing data rather than the copy, and it says why in unusually candid terms — that charging more as the dose rises turns every titration call into a revenue decision.
MadeMed appears on our semaglutide provider ranking and our combined weight loss injections ranking. Nothing on this page is a performance claim.
Tap any compound to read our plain-English guide — what the evidence shows, how it is dosed, and what it costs elsewhere.
MadeMed does not name the pharmacy that fills your prescription.
Three names across three surfaces, none reconciled, and none of them in the copy a reader sees. Its own product data attributes every injectable to Precision and every oral to AbsoluteRX, while its about page offers Red Rock Pharmacy as its example partner. The two pharmacies actually attached to the products a patient buys are visible only in the data layer. No regulatory category appears anywhere on the site or in any of its JavaScript.
A 503A pharmacy compounds for one named patient; a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Compounded peptides are not FDA-approved.
Availability depends on the product and the site gives three different answers. Injectable GLP-1 reaches 23 states, oral reaches 40, and the about page publishes the 40-state oral footprint as the states MadeMed serves. That list is wrong for injectables in both directions: it includes 20 states where injectable is unavailable, and omits Missouri, New Mexico and New York where it is. A New York patient is told on one page that MadeMed does not serve them and on another that it does.
The part they would rather you skipped
Its Terms say cancellation takes effect at the end of the current billing period with no prorated refunds. Its product FAQ says pausing stops billing immediately, not next cycle. Both are live, and they cannot both be true — and because the shortest billing period is three months paid in advance, the difference between them is several hundred dollars.
None of this is unique to MadeMed — the whole category shares it.
The providers we rank on our semaglutide provider ranking — the most specific board MadeMed sits on — in the order that board ranks them. It sells into other categories too; see the boards listed above under the bottom line.






153 more providers rank on our semaglutide provider ranking — see the full ranking. Every provider we review →
A provider comparison is half the decision. The other half is whether the compound does anything for you at all. The evidence below is where that gets settled.
Ready to get started?
Prices and plans in this category change often — check MadeMed's current pricing before you decide. Ours was read from their own site in August 2026.
Facts on this page reflect MadeMed's own public disclosures when we last checked them, in August 2026. Prices and terms change without notice — confirm on MadeMed's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved. See our disclosure and editorial policy.
MadeMed
$239/mo · Semaglutide